<?xml version="1.0" encoding="UTF-8"?>
<p id="p0220">ACE2 belongs to the renin-angiotensin-aldosterone system (RAAS), which contributes to the pathophysiology of hypertension and cardiovascular/renal diseases by maintaining homeostasis of blood pressure, electrolyte balance and inflammatory responses (
 <xref rid="bib18" ref-type="bibr">Cava et al., 2020</xref>). ACE2 can be considered as a key counterregulatory enzyme that degrades angiotensin II to angiotensin-(1â€“7), which exerts vasodilatory, natriuretic/diuretic, anti-inflammatory, and antifibrotic effects via Mas receptor (MasR) (
 <xref rid="bib1" ref-type="bibr">Abasi et al., 2020</xref>; 
 <xref rid="bib166" ref-type="bibr">Vaduganathan et al., 2020</xref>).
</p>
